Trial Profile
Ezetimibe Versus Placebo in the Treatment of Non-alcoholic Steatohepatitis
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Ezetimibe (Primary)
- Indications Non-alcoholic steatohepatitis
- Focus Therapeutic Use
- Acronyms MOZART
- 24 Jan 2017 Results of a secondary analysis assessing relationship between MRI-derived proton-density fat-fraction (PDFF), total liver volume (TLV), total liver fat index (TLFI) vs. histology published in the Alimentary Pharmacology and Therapeutics
- 12 May 2015 New trial record